MICHELLE KOTTI: Open Payments
NPI 1306883269 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 20 payments from 10 companies in 2025. Trend: 2023 $282 · 2024 $401 · 2025 $517
Food & beverage: $437Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $113 |
| UCB, Inc. | 3 | $72 |
| Amgen Inc. | 3 | $67 |
| Lilly USA, LLC | 3 | $66 |
| ABBVIE INC. | 2 | $55 |
| GENZYME CORPORATION | 2 | $46 |
| Organogenesis Inc. | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: TREMFYA, Bimzelx, OTEZLA, TALTZ, SKYRIZI, DUPIXENT, NOVACHOR, SPEVIGO.
Industry payments across GA — which companies pay providers there.
